0
0
0
To amend title IV of the Public Health Service Act to prohibit sale or transactions relating to human fetal tissue.
1/25/2025, 9:20 AM
Summary of Bill HR 727
Bill 119 HR 727, also known as the "Human Fetal Tissue Prohibition Act," aims to make changes to title IV of the Public Health Service Act in order to prevent the sale or transactions involving human fetal tissue. The bill seeks to prohibit any individual or entity from knowingly acquiring, receiving, or transferring fetal tissue obtained through an abortion for valuable consideration.
The legislation is designed to address concerns surrounding the ethical implications of the sale and use of human fetal tissue. Supporters of the bill argue that the practice of selling fetal tissue is morally wrong and should be prohibited in order to protect the dignity of human life.
If passed, the bill would impose penalties on individuals or entities found to be in violation of the prohibition, including fines and potential imprisonment. The legislation also includes provisions for the enforcement of the prohibition and the reporting of violations to the appropriate authorities. Overall, Bill 119 HR 727 represents a significant effort to regulate the use of human fetal tissue and prevent its exploitation for financial gain. The bill has garnered support from those who believe in the sanctity of human life and the need to uphold ethical standards in medical research and practice.
The legislation is designed to address concerns surrounding the ethical implications of the sale and use of human fetal tissue. Supporters of the bill argue that the practice of selling fetal tissue is morally wrong and should be prohibited in order to protect the dignity of human life.
If passed, the bill would impose penalties on individuals or entities found to be in violation of the prohibition, including fines and potential imprisonment. The legislation also includes provisions for the enforcement of the prohibition and the reporting of violations to the appropriate authorities. Overall, Bill 119 HR 727 represents a significant effort to regulate the use of human fetal tissue and prevent its exploitation for financial gain. The bill has garnered support from those who believe in the sanctity of human life and the need to uphold ethical standards in medical research and practice.
Current Status of Bill HR 727
Bill HR 727 is currently in the status of Bill Introduced since January 24, 2025. Bill HR 727 was introduced during Congress 119 and was introduced to the House on January 24, 2025. Bill HR 727's most recent activity was Referred to the House Committee on Energy and Commerce. as of January 24, 2025
Bipartisan Support of Bill HR 727
Total Number of Sponsors
1Democrat Sponsors
0Republican Sponsors
1Unaffiliated Sponsors
0Total Number of Cosponsors
11Democrat Cosponsors
0Republican Cosponsors
11Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill HR 727
Primary Policy Focus
Alternate Title(s) of Bill HR 727
To amend title IV of the Public Health Service Act to prohibit sale or transactions relating to human fetal tissue.
To amend title IV of the Public Health Service Act to prohibit sale or transactions relating to human fetal tissue.
Comments
Sponsors and Cosponsors of HR 727
Latest Bills
To authorize the Secretary of Education, in collaboration with the Secretary of Health and Human Services, to establish an interagency advisory Commission on Advancing Restorative Justice in Elementary and Secondary Education, and for other purposes.
Bill HR 8360April 17, 2026
To amend the Higher Education Act of 1965 to remove all adverse credit history related to a loan from the credit history of a borrower who has rehabilitated the loan.
Bill HR 8361April 17, 2026
To reauthorize the YouthBuild program, and for other purposes.
Bill HR 8333April 17, 2026
To raise the Foreign Service mandatory retirement age by aligning it with the Social Security Full Retirement Age, and for other purposes.
Bill HR 8346April 17, 2026
To amend the FISA Amendments Act of 2008 to extend the authorities of title VII of the Foreign Intelligence Surveillance Act of 1978 through April 30, 2026, and for other purposes.
Bill HR 8322April 17, 2026
To amend title II of the Social Security Act to repeal the retirement earnings test, and for other purposes.
Bill HR 8344April 17, 2026
To amend section 133 of title 23, United States Code, to remove a certain State funding set-aside for transportation alternative programs, and for other purposes.
Bill HR 8349April 17, 2026
To amend title XI of the Social Security Act to require the Center for Medicare and Medicaid Innovation to test a model to reduce chronic diseases by using accountable produce is medicine.
Bill HR 8355April 17, 2026
To amend the Federal Food, Drug, and Cosmetic Act to enhance drug manufacturing amount information reporting, and for other purposes.
Bill HR 8339April 17, 2026
Supporting the designation of the week of April 11 through April 17, 2026, as "Black Maternal Health Week", founded by Black Mamas Matter Alliance, Inc. (BMMA), to bring national attention to the maternal and reproductive health crisis in the United States and the importance of reducing maternal mortality and morbidity among Black women and birthing people.
Bill HRES 1183April 17, 2026